𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

✍ Scribed by Worrillow, L J; Smith, A G; Scott, K; Andersson, M; Ashcroft, A J; Dores, G M; Glimelius, B; Holowaty, E; Jackson, G H; Jones, G L

Book ID
115527168
Publisher
BMJ Publishing Group
Year
2007
Tongue
English
Weight
158 KB
Volume
45
Category
Article
ISSN
0022-2593

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Individualized estimates of second cance
Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma
✍ David C. Hodgson; Eng-Siew Koh; Tu Huan Tran; Mostafa Heydarian; Richard Tsang; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

## Abstract ## BACKGROUND. Estimates of radiation‐related second cancer risk among Hodgkin lymphoma survivors are largely based on radiation therapy (RT) fields and doses no longer in use, and these estimates do not account for differences in normal tissue dose among individual patients. This stud